ࡱ>  g2\pErin Muhlbradt Ba==x-N>8X@"1Calibri1Calibri1Calibri1Calibri1Calibri1Arial1Arial1Arial1Arial1 Calibri1Calibri1h8Cambria1,8Calibri18Calibri18Calibri1Calibri1Calibri1<Calibri1>Calibri1?Calibri14Calibri14Calibri1 Calibri1 Calibri1Calibri1Calibri1 Calibri"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_)                                                                       ff + ) , *     P  P        `                             a>   8@ @   0@ @   x@ @   p@ @   x@ @   @ @   x@ @   x@ @   x@ @ )  x@ @   @ @   8@ @   x@ @   8@ @   @ @    x@ @   x  x@ @  1 @ @   @ @   @ @   x@ @   x@ @    x@ @   x@ @  p@ @    x@ @   x@ @   8@ @   x@ @  p@ @  p@ @   x@ @   x@ @   x@ @  ||r]0\[}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-}  00\);_(*}-}  00\);_(*}-}  00\);_(*}-}  00\);_(*}-}  00\);_(*}-} 00\);_(*}-} 00\);_(*}-}B 00\);_(*}-}F 00\);_(*}-}C 00\);_(*}-}< 00\);_(*}-}9 00\);_(*}(}U 00\);_(*}(}Y 00\);_(*}(}Z 00\);_(*}(}b 00\);_(*}(}e 00\);_(*}}f}}i}(}j 00\);_(*}(}k 00\);_(*}-}o 00\);_(*}<}p 00\);_(*_)?_);_(}-}+ 00\);_(*}-}, 00\);_(*}-}- 00\);_(*}-}. 00\);_(*}-}K 00\);_(*}-}L 00\);_(*}A}1 00\);_(*;_(@_) }A}2 00\);_(*?;_(@_) }A}3 00\);_(*23;_(@_) }-}4 00\);_(*}A}0 a00\);_(*;_(@_) }A}( 00\);_(*;_(@_) }A}7 e00\);_(*;_(@_) }}5 ??v00\);_(*̙;_(@_)    }}J ???00\);_(*;_(@_) ??? ??? ??? ???}}) }00\);_(*;_(@_)    }A}6 }00\);_(*;_(@_) }}* 00\);_(*;_(@_) ??? ??? ??? ???}-}N 00\);_(*}}I 00\);_(*;_(@_)    }-}/ 00\);_(*}U}M 00\);_(*;_(@_)  }A}" 00\);_(*;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*23;_(@_) }A}# 00\);_(*;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*23;_(@_) }A}$ 00\);_(*;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*23;_(@_) }A}% 00\);_(*;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*23;_(@_) }A}& 00\);_(*;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*L;_(@_) }A}  00\);_(*23;_(@_) }A}' 00\);_(* ;_(@_) }A} 00\);_(*ef ;_(@_) }A} 00\);_(*L ;_(@_) }A}! 00\);_(*23 ;_(@_)  20% - Accent1M 20% - Accent1 ef % 20% - Accent2M" 20% - Accent2 ef % 20% - Accent3M& 20% - Accent3 ef % 20% - Accent4M* 20% - Accent4 ef % 20% - Accent5M. 20% - Accent5 ef % 20% - Accent6M2 20% - Accent6  ef % 40% - Accent1M 40% - Accent1 L % 40% - Accent2M# 40% - Accent2 L渷 % 40% - Accent3M' 40% - Accent3 L % 40% - Accent4M+ 40% - Accent4 L % 40% - Accent5M/ 40% - Accent5 L % 40% - Accent6M3 40% - Accent6  Lմ % 60% - Accent1M 60% - Accent1 23 % 60% - Accent2M$ 60% - Accent2 23ږ % 60% - Accent3M( 60% - Accent3 23כ % 60% - Accent4M, 60% - Accent4 23 % 60% - Accent5M0 60% - Accent5 23 %! 60% - Accent6M4 60% - Accent6  23 % "Accent1AAccent1 O % #Accent2A!Accent2 PM % $Accent3A%Accent3 Y % %Accent4A)Accent4 d % &Accent5A-Accent5 K % 'Accent6A1Accent6  F %(Bad9Bad  %) Calculation Calculation  }% * Check Cell Check Cell  %????????? ???+ Comma,( Comma [0]-&Currency.. Currency [0]/Explanatory TextG5Explanatory Text % 0Good;Good  a%1 Heading 1G Heading 1 I}%O2 Heading 2G Heading 2 I}%?3 Heading 3G Heading 3 I}%234 Heading 49 Heading 4 I}% 5InputuInput ̙ ??v% 6 Linked CellK Linked Cell }% 7NeutralANeutral  e%3Normal %8 Normal 109 Normal 119 Normal 11 %: Normal 12; Normal 14< Normal 169 Normal 16 % =Normal 2> Normal 2 2 ?Normal 3 @Normal 4 ANormal 5 BNormal 67Normal 6 %C Normal 6 2; Normal 6 2 %D Normal 6 3 ENormal 7 FNormal 87Normal 8 % GNormal 9H Normal_Sheet1 INoteb Note   JOutputwOutput  ???%????????? ???K$Percent LTitle1Title I}% MTotalMTotal %OON Warning Text? Warning Text %XTableStyleMedium2PivotStyleLight16`SEND Changes 2012-12-21R]Sheet2^Sheet38 J Request Code Change TypeNCI CodeCDISC Term TypeCDISC Codelist (Short Name)CDISC Codelist (Long Name)Change SummaryOriginalNewIC-code DefinitionC83610NCI Preferred Term SDTM-COUNTRYCountryRModify Existing Term; Update the NCI PT column to reflect what is in NCIt databaseSaint Martin, FrenchSaint Martin (French Part)C16359BoliviaBolivia, Plurinational State ofC16793Libyan Arab JamahiriyaLibyaC17164 Saint Helena,Saint Helena, Ascension and Tristan da CunhaC17250 VenezuelaVenezuela, Bolivian Republic ofC49572 SDTM-DOMAINDomain Abbreviationadd period to end of sentence.The Demographics domain includes a set of essential standard variables that describe each subject in a clinical study. It is the parent domain for all other observations for human clinical subjectsThe Demographics domain includes a set of essential standard variables that describe each subject in a clinical study. It is the parent domain for all other observations for human clinical subjects.SynonymC1001049Update Synonym because this is term being used elsewhere.- - -C25473 SDTM-FREQ Frequency$Add (NCI) to end of CDISC definitionOccurring or done each day.!Occurring or done each day. (NCI)C66726SDTM-FRMPharmaceutical Dosage Form&Modify Existing Term; C66726 - remove synonym from codelist term. Remove Dose Form from synonym column.; Remove Dose Form from synonym column. The presence of the additional synonym screws up our report writers. Codelist values cannot have additional synonyms other than the codelist long name.%Pharmaceutical Dosage Form; Dose FormC42896%Coated Pellets in Capsule Dosage Form$Coated Pellet in Capsule Dosage FormC42904.Delayed Release Pellets in Capsule Dosage Form-Delayed Release Pellet in Capsule Dosage FormC42899/Concentrate for Injectable Solution Dosage Form,Concentrated Injectable Solution Dosage FormC42918+Extended Release Coated Pellets Dosage Form*Extended Release Coated Pellet Dosage FormC42898$Concentrate for Solution Dosage Form!Concentrated Solution Dosage FormC60891Concentrate Dosage FormConcentrated Dosage FormC47890Diaphragm Dosage FormVaginal Diaphragm Dosage FormC60994&Gel Forming Drops Solution Dosage Form%Gel Forming Drop Solution Dosage FormC60992Drops Solution Dosage FormDrop Solution Dosage FormC60995Drops Suspension Dosage FormDrop Suspension Dosage FormC60997#Tablet Coated Particles Dosage Form"Tablet Coated Particle Dosage FormC42997,Delayed Release Particles Tablet Dosage Form+Delayed Release Particle Tablet Dosage FormC610068Tablet Orally Disintegrating Delayed Release Dosage Form8Orally Disintegrating Delayed Release Tablet Dosage FormC42895Add (FDA) at end of definitionA solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. (NCI)A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or 'shell' made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. (FDA)C42901A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice.A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice. (FDA)C42934A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2). A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. (NCI)A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2). A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. (FDA)C42966SA suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. (NCI)SA suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. (FDA)C42968A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms Extended Release Film and System. (NCI)A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms Extended Release Film and System. (FDA)C42943CA small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. (NCI)E"A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. (FDA)"C429709Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. (NCI)9Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. (FDA)C47914 A long narrow piece of < material.&A long narrow piece of material. (FDA)C47898A small piece of relatively flat absorbent material that contains a drug. A swab may also be attached to one end of a small stick. A swab is typically used for applying medication or for cleansing. (NCI)A small piece of relatively flat absorbent material that contains a drug. A swab may also be attached to one end of a small stick. A swab is typically used for applying medication or for cleansing. (FDA)C429308A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. (NCI)8A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. (FDA)C61005hA tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet).nA tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet). (FDA)C47887=Add a space in between period and (FDA) at end of definition.A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin.(FDA)A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin. (FDA)C47912A porous, interlacing, absorbent material that contains a drug. It is typically used for applying or introducing medication, or for cleansing. A sponge usually retains its shape.(FDA)A porous, interlacing, absorbent material that contains a drug. It is typically used for applying or introducing medication, or for cleansing. A sponge usually retains its shape. (FDA)C42994A liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.(FDA)A liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. (FDA)C42910A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.(FDA)A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration. (FDA)C42678;Add space in between period and (FDA) at end of definition.A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances.(FDA)A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances. (FDA)C42914lAn emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.(FDA)mAn emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally. (FDA)C42977 A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution).(FDA) A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (FDA)C45413hA material applied to the inside of the dental cavity, for protection or insulation of the surface.(FDA)iA material applied to the inside of the dental cavity, for protection or insulation of the surface. (FDA)C42993$Remove (NCI) from end of definition.A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature. (NCI)C28012SDTM-LAT Laterality7Code for the term needs to change from C28012 to C68598C68598C33318Adenoid; Pharyngeal TonsilSubmission ValueC2948 SDTM-NEOPLASM Neoplasm Type&Remove duplicate term from spreadsheet$CHORIOEPITHELIOMA; CHORIOEPITHELIOMACHORIOEPITHELIOMAC82973)Remove duplicate synonym from spreadsheetSUBCAPSULAR CELL TUMOR, ADRENALC9145&OSTEOGENIC SARCOMA; OSTEOGENIC SARCOMAOSTEOGENIC SARCOMAC8973Endometrial Stromal SarcomaEndometrioid Stromal SarcomaC27096"Undifferentiated Embryonal Sarcoma$Undifferentiated (Embryonal) SarcomaC85571 SDTM-PKPARM PK ParametersModify Existing Term; C85571 - Change submission value in PKPARM codelist only.; Long name in PKPARM codelist needs to change to AURC to Last Nonzero Rate. Copy/paste error occurred with last publication. The PKPARMCD values are fine.AURC Dosing to Last ConcAURC to Last Nonzero RateC85493SDTM-PKPARM; SDTM-PKPARMCD!PK Parameters; PK Parameters Code0CDSIC SDTM Pharmacokinetic Parameter Terminology0CDISC SDTM Pharmacokinetic Parameter TerminologyC85628 SDTM-PKUNITPK Parameter Units of MeasureModify Existing Term; C85628 h*ng/mL/mg/kg; Codelist:C85494 PK Parameter Units of Measure; The CDISC Synonym 'h*ng/mL/mg' should be 'h*ng/mL/mg/kg.' The '/kg' part on the end is missing. h*ng/mL/mg h*ng/mL/mg/kgC85600Modify Existing Term; Change c-code of C85600 in the PKUNIT codelist to C67372.; Concept merge; NCI editors have decided 'per day' and 'per 24 hours' are synonymous.C67372C67331aAdd Synonym of Picogram per Deciliter due to use of this term and synonym in another spreadsheet.Picogram per DeciliterC17648 SDTM-PORTOTPortion/TotalityGCode for the term needs to change from C17648 to C78728 on spreadsheet.C78728C66968 SDTM-UNITUnitModify Existing Term; C66968 needs to change to C25473.; We determined /day and /24 Hours is synonymous and will merge these terms.C68858m3Standard Cubic MeterC73715 g/animal/weekGram per Animal per WeekC73718 g/cage/weekGram per Cage per WeekC73748mL/animal/weekMilliliter per Animal per WeekC73752 mL/cage/weekMilliliter per Cage per Week Gram per DayGram per Day; g/d; gram/dayC73753SDTM-UNIT; SDTM-PKUNIT#Unit; PK Parameter Units of MeasureModify Existing Term; C73753 is being merged into C67410.; CDISC is using C73753 in both units codelists. change c-code to C67410C67410II8Removal of existing synonym and addition of new synonym.LIBYAN ARAB JAMAHIRIYALIBYAn/aC64497CDISC Submission Value; Synonym3Update Submission Value. Addition of a new synonym.C64528C64531C71127C64535C64529C89788C67069IIIC103390TermCreate New TermGSee published spreadsheet for new term information. CDISC EVERY 5 WEEKSC103389GSee published spreadsheet for new term information. CDISC EVERY 8 WEEKSC103348SDTM-LBTEST; SDTM-LBTESTCD*Laboratory Test Code; Laboratory Test NameYSee published spreadsheet for new term information. CDISC ACT; Activated Coagulation TimeC103360`See published spreadsheet for new term information. CDISC CAPHOSPD; Calcium - Phosphorus ProductC103404PSee published spreadsheet for new term information. CDISC HBDNA; Hepatitis < B DNAC103419aSee published spreadsheet for new term information. CDISC NAGASE; N-acetyl-beta-D-glucosaminidaseC103430LSee published spreadsheet for new term information. CDISC PCT; ProcalcitoninC103343KSee published spreadsheet for new term information. CDISC PG; ProstaglandinC103431PSee published spreadsheet for new term information. CDISC PGD2; Prostaglandin D2C103432ZSee published spreadsheet for new term information. CDISC PGD2S; Prostaglandin D2 SynthaseC103434PSee published spreadsheet for new term information. CDISC PGE1; Prostaglandin E1C103435PSee published spreadsheet for new term information. CDISC PGE2; Prostaglandin E2C103433XSee published spreadsheet for new term information. CDISC PGES; Prostaglandin E SynthaseC103436WSee published spreadsheet for new term information. CDISC PGF1A; Prostaglandin F1 AlphaC103437WSee published spreadsheet for new term information. CDISC PGF2A; Prostaglandin F2 AlphaC103427XSee published spreadsheet for new term information. CDISC PLATAGGR; Platelet AggregationC103451ZSee published spreadsheet for new term information. CDISC PTHW; Parathyroid Hormone, WholeC103440XSee published spreadsheet for new term information. CDISC RUBIGGAB; Rubella IgG AntibodyC103446NSee published spreadsheet for new term information. CDISC TGLOB; ThyroglobulinC103445NSee published spreadsheet for new term information. CDISC TXB2; Thromboxane B2C103448YSee published spreadsheet for new term information. CDISC VITECHOL; Vitamin E/CholesterolC103449KSee published spreadsheet for new term information. CDISC VITK1; Vitamin K1C103450USee published spreadsheet for new term information. CDISC VLDLPSZ; VLDL Particle SizeC103453XSee published spreadsheet for new term information. CDISC ALBPROT; Albumin/Total ProteinC103349TSee published spreadsheet for new term information. CDISC ALTCPHRL; Alpha TocopherolC103352TSee published spreadsheet for new term information. CDISC AMYLB38; Amyloid Beta 1-38C103353TSee published spreadsheet for new term information. CDISC AMYLB40; Amyloid Beta 1-40C91372_See published spreadsheet for new term information. CDISC ANGLBIND; Antiglobulin Test, IndirectC103351VSee published spreadsheet for new term information. CDISC APLSMA2; Alpha-2 AntiplasminC103354RSee published spreadsheet for new term information. CDISC APOA4; Apolipoprotein A4C103355RSee published spreadsheet for new term information. CDISC APOA5; Apolipoprotein A5C103356fSee published spreadsheet for new term information. CDISC APOBAPA1; Apolipoprotein B/Apolipoprotein A1C103350]See published spreadsheet for new term information. CDISC ATPVITE; Alpha Tocopherol/Vitamin EC103358fSee published spreadsheet for new term information. CDISC B2G1GGAB; Beta-2 Glycoprotein 1 IgG AntibodyC103359fSee published spreadsheet for new term information. CDISC B2G1GMAB; Beta-2 Glycoprotein 1 IgM AntibodyC103407PSee published spreadsheet for new term information. CDISC BLASTIMM; ImmunoblastsC103362WSee published spreadsheet for new term information. CDISC CA15_3AG; Cancer Antigen 15-3C103361QSee published spreadsheet for new term information. CDISC CA1AG; Cancer Antigen 1C103357OSee published spreadsheet for new term information. CDISC CATNINB; Beta CateninC103364BSee published spreadsheet for new term information. CDISC CD1; CD1C103365DSee published spreadsheet for new term information. CDISC CD14; CD14C103366BSee published spreadsheet for new term information. CDISC CD2; CD2C103368DSee published spreadsheet for new term information. CDISC CD20; CD20C103367PSee published spreadsheet for new term information. CDISC CD2LY; CD2/LymphocytesC103369BSee published spreadsheet for new term information. CDISC CD5; CD5C103370DSee published spreadsheet for new term information. CDISC CD56; CD56C103381]See published spreadsheet for new term information. CDISC CDFTXN; Clostridium difficile ToxinC103380gSee published spreadsheet for new term information. CDISC CETPA; Cholesteryl Ester Transfer Protein ActC103383PSee published spreadsheet for new term information. CDISC COL4; Collagen Type IVC103363\See published spreadsheet for new term information. CDISC CRDIGMAB; Cardiolipin IgM AntibodyC103382cSee published spreadsheet for new term information. CDISC CTTIGGAB; Clostridium tetani IgG AntibodyC103345_See published spreadsheet for new term information. CDISC DOPAC; 3,4-Dihydroxyphenylacetic AcidC103387aSee published spreadsheet for new term information. CDISC DPPIVA; Dipeptidyl Peptidase-4 ActivityC103388[See published spreadsheet for new term information. CDISC DPTIGGAB; Diphtheria IgG AntibodyC103386jSee published spreadsheet for new term information. CDISC DRVVTRT; Dilute Russell's Viper Venom Time RatioC103395USee published spreadsheet for new term information. CDISC FACTIXA; Factor IX ActivityC103396SSee published spreadsheet for new term information. CDISC FACTVA; Factor V ActivityC103397WSee published spreadsheet for new term information. CDISC FACTVIIA; Factor VII ActivityC103398XSee published spreadsheet for new term information. CDISC FCTVIIAA; Factor VIIa ActivityC103399XSee published spreadsheet for new term information. CDISC FCTVIIIA; Factor VIII ActivityC103405XSee published spreadsheet for new term information. CDISC HALBAB; Human Albumin AntibodyC103406ZSee published spreadsheet for new term information. CDISC HAMAB; Human Anti-Mouse AntibodyC103402SSee published spreadsheet for new term information. CDISC HDLPSZ; HDL Particle SizeC103403dSee published spreadsheet for new term information. CDISC HPLIGGAB; Helicobacter pylori IgG AntibodyC103408[See published spreadsheet for new term information. CDISC IAIGGAB; Influenza A IgG AntibodyC103409[See published spreadsheet for new term information. CDISC IBIGGAB; Influenza B IgG AntibodyC103410ISee published spreadsheet for new term information. CDISC ILE; IsoleucineC103412SSee published spreadsheet for new term information. CDISC LDLPSZ; LDL Particle SizeC75354YSee published spreadsheet for new term information. CDISC LSD; Lysergic Acid DiethylamideC103413NSee published spreadsheet for new term information. CDISC LTB4; Leukotriene B4C103414NSee published spreadsheet for new term information. CDISC LTD4; Leukotriene D4C103415NSee published spreadsheet for new term information. CDISC LTE4; Leukotriene E4 32040; 32041C75359aSee published spreadsheet for new term information. CDISC MDMA; 3,4-methylenedioxymethamphetamineC103418USee published spreadsheet for new term information. CDISC MYELINAB; Myelin AntibodiesC103344]See published spreadsheet for new term information. CDISC TXB2_D11; 11-Dehydro-Thromboxane B2C74606C-code; DefinitionSDTM-LBTESTCD; SDTM-LBTESTiUpdate the CDISC definition and change in NCI c-code. The meaning of the value has changed significantly.hC-code: C74606; Definition: A measurement of the CD19 expressing cells B cells in a biological specimen.dC-code: C103808; Definition: A count of the CD19 expressing cells per unit in a biological specimen.C74607bC-code: C74607; Definition: A measurement of the CD3 T expressing cells in a biological specimen.cC-code: C103809; Definition: A count of the CD3 expressing cells per unit in a biological specimen.C74608aC-code: C74608; Definition: A measurement of the CD4 T expressing cells in a biological specimen.cC-code: C103810; Definition: A count of the CD4 expressing cells per unit in a biological specimen.C74609aC-code: C74609; Definition: A measurement of the CD8 T expressing cells in a biological specimen.cC-code: C103811; Definition: A count of the CD8 expressing cells per unit in a biological specimen.C74635C-code: C74635; Definition: A relative measurement (ratio or percentage) of CD19 B cells to all lymphocytes in a biological specimen.C-code: C103812; Definition: A relative measurement (ratio or percentage) of CD19 expressing cells to all lymphocytes in a biolog< ical specimen.C74636 C-code: C74636; Definition: A relative measurement (ratio or percentage) of CD3 T cells to all lymphocytes in a biological specimen.C-code: C103813; Definition: A relative measurement (ratio or percentage) of CD3 expressing cells to all lymphocytes in a biological specimen.C74639C-code: C74639; Definition: A relative measurement (ratio or percentage) of CD8 T cells to all lymphocytes in a biological specimen.C-code: C103816; Definition: A relative measurement (ratio or percentage) of CD8 expressing cells to all lymphocytes in a biological specimen.C74638C-code: C74638; Definition: A relative measurement (ratio or percentage) of CD4 T cells to all lymphocytes in a biological specimen.C-code: C103815; Definition: A relative measurement (ratio or percentage) of CD4 expressing cells to all lymphocytes in a biological specimen.C74637C-code: C74638; Definition: A relative measurement (ratio or percentage) of CD4 T cells to the CD8 T cells in a biological specimen.C-code: C103815; Definition: A relative measurement (ratio or percentage) of CD4 expressing cells to the CD8 expressing cells in a biological specimen.C82006+Update to CDISC Definition for consistency.3A measurement of the CD40 in a biological specimen.<A count of the CD40 cells per unit in a biological specimen.C82007:A measurement of the CD40 ligand in a biological specimen.CA count of the CD40 ligand cells per unit in a biological specimen.C74789(Update the CDISC Definition for clarity.IA measurement of the intact parathyroid hormone in a biological specimen.rA measurement of the intact parathyroid hormone (consisting of amino acids 1-84 or 7-84) in a biological specimen.C74907'Update to CDISC Definition for clarity.8A measurement of the Vitamin K in a biological specimen.>A measurement of the total Vitamin K in a biological specimen.C102277bCorrection to the CDISC Submission Value. Removal of existing synonym and addition of new synonym.C96696Addition of a new synonym.!Dilute Russell's Viper Venom Time;Dilute Russell's Viper Venom Time; Lupus Anticoagulant TestC98725 Factor IXFactor IX; Christmas FactorC98726Factor VFactor V; Labile FactorC81960#Factor VIII; Anti-hemophilic Factor'Factor VII; Proconvertin; Stable FactorC81961 Factor VIIIC102272*Factor XIV; Autoprothrombin IIA; Protein C=Factor XIV; Autoprothrombin IIA; Protein C; Protein C AntigenC74630Removal of synonyms.ALeukemic Blasts; Leukemic Lymphoblasts; Immunoblastic LymphocytesLeukemic BlastsC98774Prothrombin Activity(Prothrombin Activity; Factor II ActivityC84809Amyloid Beta 42; Amyloid Beta 42 Protein; A measurement of the 42 amino acid amyloid beta protein isoform in a biological specimen.Amyloid Beta 42; Amyloid Beta 42 Protein; Amyloid Beta 1-42; A measurement of amyloid beta protein which is composed of peptides 1 to 42 in a biological specimen.C74906Vitamin E; Tocopherol Vitamin EC3809C-code; Synonym2Removal of existing synonym. Change in NCI C-code.FC-code: C3809; Synonym: NEUROENDOCRINE TUMOR NOS; NEUROENDOCRINE TUMORC-code: C6963; Synonym: - - -C3194Removal of existing synonym.MALIGNANT HIBERNOMAC3461 LYMPHOMA, LYMPHOCYTIC, MALIGNANTC4267BENIGN CONNECTIVE AND SOFT TISSUE NEOPLASM; BENIGN CONNECTIVE AND SOFT TISSUE TUMOR; BENIGN MESENCHYMAL CELL NEOPLASM; BENIGN NEOPLASM OF THE SOFT TISSUE AND BONE; BENIGN TUMOR OF THE SOFT TISSUE AND BONEC60781ASTROCYTOMA, DIFFUSEC2921BASAL CELL EPITHELIOMA; BASAL CELL CANCER; BASAL CELL CARCINOMA OF SKIN; BASAL CELL CARCINOMA OF THE SKIN; BASAL CELL CARCINOMA; BASAL CELL EPITHELIOMA; BASAL CELL SKIN CARCINOMA; BASILOMA; BCC; RODENT ULCERBASAL CELL EPITHELIOMA; BASAL CELL CANCER; BASAL CELL CARCINOMA OF SKIN; BASAL CELL CARCINOMA OF THE SKIN; BASAL CELL CARCINOMA; BASAL CELL EPITHELIOMA; BASAL CELL SKIN CARCINOMA; BCCC67012-ARRHENOBLASTOMA, BENIGN; BENIGN ANDROBLASTOMABENIGN ANDROBLASTOMAC48314zNEURAL CREST TUMOR, BENIGN; NEUROENDOCRINE TUMOR, BENIGN; BENIGN PARAGANGLIONIC NEOPLASM; BENIGN NEUROENDOCRINE CELL TUMOR@BENIGN PARAGANGLIONIC NEOPLASM; BENIGN NEUROENDOCRINE CELL TUMORC3740OSTEOFIBROMA, BONE; DESMOID TUMOR OF BONE; DESMOPLASTIC FIBROMA OF BONE; DESMOPLASTIC FIBROMA OF THE BONE; DESMOPLASTIC FIBROMA; OSSEOUS DESMOPLASTIC FIBROMADESMOID TUMOR OF BONE; DESMOPLASTIC FIBROMA OF BONE; DESMOPLASTIC FIBROMA OF THE BONE; DESMOPLASTIC FIBROMA; OSSEOUS DESMOPLASTIC FIBROMAC41477Remove of existing synonym and addition of new synonym._EOSINOPHIL CARCINOMA; ACIDOPHIL ADENOCARCINOMA; ACIDOPHIL CARCINOMA; EOSINOPHIL ADENOMCARCINOMA^EOSINOPHIL CARCINOMA; ACIDOPHIL ADENOCARCINOMA; ACIDOPHIL CARCINOMA; EOSINOPHIL ADENOCARCINOMAC8923DIGUGLIELMO'S DISEASE; DIGUGLIELMO'S SYNDROMA; ERYTHROBLASTIC LEUKEMIA; ACUTE ERYTHROBLASTIC LEUKEMIA; DI GUGLIELMO'S DISEASE; M6 ACUTE MYELOID LEUKEMIA; DI GUGLIELMO DISEASE; FAB M6YERYTHROBLASTIC LEUKEMIA; ACUTE ERYTHROBLASTIC LEUKEMIA; M6 ACUTE MYELOID LEUKEMIA; FAB M6C8810hOSSIFYING SARCOMA; EXTRAOSSEOUS OSTEOSARCOMA; EXTRASKELETAL OSTEOGENIC SARCOMA; SOFT TISSUE OSTEOSARCOMAUEXTRAOSSEOUS OSTEOSARCOMA; EXTRASKELETAL OSTEOGENIC SARCOMA; SOFT TISSUE OSTEOSARCOMAC26712GELATINOUS ADENOCARCINOMA; MUCOID ADENOCARCINOMA; MUCINOUS CARCINOMA; MUCOUS; ADENOCARCINOMA; COLLOID ADENOCARCINOMA; COLLOID CARCINOMA; MUCOID CARCINOMA; MUCOUS CARCINOMA; GELATINOUS CARCINOMAGELATINOUS ADENOCARCINOMA; MUCOID ADENOCARCINOMA; MUCINOUS CARCINOMA; MUCOUS ADENOCARCINOMA; COLLOID ADENOCARCINOMA; COLLOID CARCINOMA; MUCOID CARCINOMA; MUCOUS CARCINOMA; GELATINOUS CARCINOMAC2942HEPATOCHOLANGIOMA; CHOLANGIOMA; ADENOMA OF BILE DUCT; ADENOMA OF THE BILE DUCT; CHOLANGIOADENOMA; CHOLANGIOFIBROMA; HEPATOCHOLANGIOCELLULAR ADENOMAHEPATOCHOLANGIOMA; CHOLANGIOMA; ADENOMA OF BILE DUCT; ADENOMA OF THE BILE DUCT; CHOLANGIOADENOMA; HEPATOCHOLANGIOCELLULAR ADENOMAC35417PERIPHERAL CHOLANGIOCARCINOMA; INTRAHEPATIC CARCINOMA OF BILE DUCT; INTRAHEPATIC CARCINOMA OF THE BILE DUCT; INTRAHEPATIC BILE DUCT CARCINOMA; HEPATOCHOLANGIOCELLULAR CARCINOMAnINTRAHEPATIC CARCINOMA OF BILE DUCT; INTRAHEPATIC CARCINOMA OF THE BILE DUCT; INTRAHEPATIC BILE DUCT CARCINOMAC3208LYMPHOMA, PLEOMORPHIC, MALIGNANT; LYMPHOMA (HODGKIN AND NON-HODGKIN); LYMPHOMA (HODGKIN'S AND NON-HODGKIN'S); MALIGNANT LYMPHOMA^LYMPHOMA (HODGKIN AND NON-HODGKIN); LYMPHOMA (HODGKIN'S AND NON-HODGKIN'S); MALIGNANT LYMPHOMAC670063ARRHENOBLASTOMA, MALIGNANT; MALIGNANT ANDROBLASTOMAMALIGNANT ANDROBLASTOMAC4205GRANULOSA CELL NEOPLASMMALIGNANT GRANULOSA CELL TUMORC9295MAST CELL PROLIFERATIVE DISEASE; TUMOR OF MAST CELLS; NEOPLASM OF MAST CELLS; MASTOCYTOSIS; NEOPLASM OF THE MAST CELLS; MAST CELL TUMOR; TUMOR OF THE MAST CELLSMAST CELL PROLIFERATIVE DISEASE; TUMOR OF MAST CELLS; NEOPLASM OF MAST CELLS; NEOPLASM OF THE MAST CELLS; MAST CELL TUMOR; TUMOR OF THE MAST CELLSC39807QRENAL TUBULE CARCINOMA; MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA OF THE KIDNEY9MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA OF THE KIDNEYC3736 MYELIPOMA MYELOLIPOMAC3049C3270&NEUROBLASTOMA (SCHWANNIAN STROMA-POOR)ENEUROBLASTOMA (SCHWANNIAN STROMA-POOR); NEURAL CREST TUMOR, MALIGNANTC3773wNEURAL CREST TUMOR, MALIGNANT; NEUROENDOCRINE TUMOR, MALIGNANT; NEUROENDOCRINE CELL CARCINOMA; NEUROENDOCRINE CARCINOMAXNEUROENDOCRINE TUMOR, MALIGNANT; NEUROENDOCRINE CELL CARCINOMA; NEUROENDOCRINE CARCINOMAC3286)ODONTOMA, UNDETERMINED; ODONTOGENIC TUMORODONTOGENIC TUMORC4858DECIDUOMA NOS; PLACENTA NEOPLASMS; PLACENTA TUMORS; PLACENTA TUMOR; TUMOR OF PLACENTA; TUMOR OF THE PLACENTA; PLACENTAL TUMORS; PLACENTAL TUMOR; NEOPLASM OF THE PLACENTA; PLACENTA NEOPLASM; NEOPLASM OF PLACENTAPLACENTA NEOPLASMS; PLACENTA TUMORS; PLACENTA TUMOR; TUMOR OF PLACENTA; TUMOR OF THE PLACENTA; PLACENTAL TUMORS; PLACENTAL TUMOR; NEOPLASM OF THE PLACENTA; PLACENTA NEOPLASM; NEOPLASM OF PLACENTAC6433POLYP, STROMAL; POLYP OF THE ENDOMETRIUM; ENDOMETRIAL STROMAL POLYP; POLYP OF ENDOMETRIUM; ADENOMA; ENDOMETRIAL; GLANDULAR ENDOMETRIAL POLYP; <ENDOMETRIAL ADENOMA|POLYP OF THE ENDOMETRIUM; ENDOMETRIAL STROMAL POLYP; POLYP OF ENDOMETRIUM; ADENOMA, ENDOMETRIAL; GLANDULAR ENDOMETRIAL POLYPC7540ISMALL B-CELL LYMPHOCYTIC LYMPHOMA; SLL; B-CELL SMALL LYMPHOCYTIC LYMPHOMAkSMALL B-CELL LYMPHOCYTIC LYMPHOMA; SLL; B-CELL SMALL LYMPHOCYTIC LYMPHOMA; LYMPHOMA, LYMPHOCYTIC, MALIGNANTC4209QSee published spreadsheet for new term information. CDISC ARRHENOBLASTOMA, BENIGNC4210TSee published spreadsheet for new term information. CDISC ARRHENOBLASTOMA, MALIGNANTC7173YSee published spreadsheet for new term information. CDISC ASTROCYTOMA, DIFFUSE, MALIGNANTC103391KSee published spreadsheet for new term information. CDISC BASALIOMA, BENIGNC53684eSee published spreadsheet for new term information. CDISC CONNECTIVE AND SOFT TISSUE NEOPLASM, BENIGNC103394NSee published spreadsheet for new term information. CDISC HIBERNOMA, MALIGNANTC103392TSee published spreadsheet for new term information. CDISC OSTEOFIBROMA, BONE, BENIGNC96805bSee published spreadsheet for new term information. CDISC PERIPHERAL CHOLANGIOCARCINOMA, MALIGNANT$gram/day; g/d; g/24h; gram/24 Hours 2Gram per Day; gram/day; g/d; g/24h; gram/24 Hours C94636 SDTM-ROUTERoute of AdministrationCSee published spreadsheet for new term information. CDISC SUBTENONC64984FSee published spreadsheet for new term information. CDISC INTRACAMERALC64906DSee published spreadsheet for new term information. CDISC OROMUCOSALC12472Adipose Tissue; Body Fat$Adipose Tissue; Body Fat; Fat TissueCDISC Submission ValueC74993$Deprecate term. Duplicate of C66975.C-code: C74993; Submission Value: mg/g/day; Synonym: Milligram per Gram per Day; Definition: A dose calculation unit expressed in milligram(s) per gram per period of time equal to twenty-four hours. (NCI)C96599 Ehrlich UnitsEhrlich Units; EU/dL2Gram per Day; g/d; gram/day; g/24h; gram/24 Hours C66975Gram per Kilogram per Day#Gram per Kilogram per Day; mg/g/daym3; Standard Cubic MeterC103452=See published spreadsheet for new term information. CDISC /mLC64693=See published spreadsheet for new term information. CDISC cGyC69073>See published spreadsheet for new term information. CDISC mL/sSDTM-VSTEST; SDTM-VSTESTCD,Vital Signs Test Name; Vital Signs Test CodeAdipose Tissue SEND-CLCAT!Category for Clinical Observation^Modify Existing Term; C100104; Update NCI PT on Spreadsheet. Change Finding to Sign or SymptomFindingSign or SymptomC12510 SEND-SPECSpecimenDModify Existing Term; C12510; Add (NCI) to the end of the definitionThe uppermost portion of the brainstem located between the pons and the diencephalon. The midbrain contains the cerebral peduncles, oculomotor, trochlear and red nuclei, substantia nigra and various other nuclei and tracts.The uppermost portion of the brainstem located between the pons and the diencephalon. The midbrain contains the cerebral peduncles, oculomotor, trochlear and red nuclei, substantia nigra and various other nuclei and tracts. (NCI)C12499AModify Existing Term; C12499; Remove (NCI) from end of definitionThe portion of the ear located within the temporal bone that is involved in both hearing and balance and includes the semicircular canals, vestibule, and cochlea. (from American Heritage Dictionary online) (NCI)The portion of the ear located within the temporal bone that is involved in both hearing and balance and includes the semicircular canals, vestibule, and cochlea. (from American Heritage Dictionary online)Modify Existing Term; C33318; Update to CDISC Synonym column due to use of this concept in another codelist. Add Pharyngeal Tonsil as a synonym.AdenoidC12298Modify Existing Term; C12298; Update to CDISC Synonym column due to use of this concept in another codelist. Add RETROPERITIONEAL CAVITY as a synonym.RETROPERITONEAL CAVITYA solid body of various weights and shapes, adapted for introduction into the rectal orifice of the human body; they usually melt, soften, or dissolve at body temperature.?SUBCAPSULAR CELL TUMOR, ADRENAL|SUBCAPSULAR CELL TUMOR, ADRENAL.Submission Value: BIS; Synonym: Twice per week@Submission Value: 2 TIMES PER WEEK; Synonym: Twice per week; BIS2Submission Value: TIS; Synonym: Three times a weekDSubmission Value: 3 TIMES PER WEEK; Synonym: Three times a week; TIS0Submission Value: QIS; Synonym: 4 times per weekBSubmission Value: 4 TIMES PER WEEK; Synonym: 4 times per week; QIS-Submission Value: Q2S; Synonym: Every 2 weeks<Submission Value: EVERY 2 WEEKS; Synonym: Every 2 weeks; Q2S-Submission Value: Q3S; Synonym: Every 3 weeks<Submission Value: EVERY 3 WEEKS; Synonym: Every 3 weeks; Q3S-Submission Value: Q4S; Synonym: Every 4 weeks<Submission Value: EVERY 4 WEEKS; Synonym: Every 4 weeks; Q4S-Submission Value: Q6S; Synonym: Every 6 Weeks<Submission Value: EVERY 6 WEEKS; Synonym: Every 6 Weeks; Q6S3Submission Value: QS; Synonym: Every week; Per Week?Submission Value: EVERY WEEK; Synonym: Every week; Per Week; QSOSubmission Value: APPTLAS; Synonym: Lupus Anticoagulant Sensitive APTT; APPT-LAOSubmission Value: APTTLAS; Synonym: Lupus Anticoagulant Sensitive APTT; APTT-LANEURAL CREST TUMOR, BENIGNC90351 SEND-DSDECODStandardized Disposition TermAAn indication that the subject's death was due to a mishap. (NCI)gAn indication that the subject's death or sacrifice was due to a mishap or technical/operational error.C77678The anatomic site at which a tissue, graft, or radioactive material is inserted. This term may also refer to the site of the uterus at which the early embryo is attached.The anatomic site at which a material such as a tissue, graft, device or radioactive material is inserted with some intended degree of permanence. This term may also refer to the site of the uterus at which the early embryo is attached.C88024MChange to Submission Value: this is part of the Ileum, hence SMALL INTESTINE."LARGE INTESTINE, SACCULUS ROTUNDUS"SMALL INTESTINE, SACCULUS ROTUNDUSC3828<Change C-code; Add synonym; Change definition; Change NCI PT.C3828; SY: - - -; Definition: A malignant neoplasm of the liver containing unequivocal elements of both hepatocellular and cholangiocarcinoma intimately admixed.; NCI PT: A malignant neoplasm of the liver containing unequivocal elements of both hepatocellular and cholangiocarcinoma intimately admixed.!C103393; SY: HEPATOCHOLANGIOCELLULAR CARCINOMA; Definition: A malignant mixed neoplasm of the liver comprising neoplastic hepatocytes and bile duct epithelial cells; both elements displaying evidence of malignancy.; NCI PT: Experimental Organism Malignant Hepatocholangiocellular Carcinoma8 =99t:;c*==%?@.AFB =C E PeWZ^&b# jgj'IlmAmPo@p|r?sBsltuTvQvswx nz{ } !1 [s @Xt,+C2&s*-!  ڤ  ˱2&4(QE{K[WT \ : yIccB g2 0*"4:GY\  dMbP?_*+%,&ffffff?'ffffff?(?)?",B333333?333333?TH&<3U}  } } !} "} !                                  W W W W W W W W W~ O@ O \& O Og Qh Oi Qj Qk~ O@ O \l O Om Qn Oo Qp Qq~ O@@ O \r O Om Qn Os Qt Qu~ O@@ O \ O% Om Qn Ov Qw Q~ O@ O \x O% Om Qn Oy Q( Qz~ Q@@ O Q Q Q Q O Q Q~ Q@@ O O Q O Q O Q Q~ Q@@ O O Q O Q O Q Q~ Q@@ O O Q O Q O Q Q~ Q@@ O O Q O Q O Q Q~ Q@ O Z Q Z Q! Z" U# O$~ Q@ O Z) Q X* Q+ X, U- O.~ Q@@ Q Q/ Q% Q0 Q1 O2 Q3 Q1~ Q@@ O O4 Q O0 Q1 O Q5 Q6~ Q@@ O O7 Q O0 Q1 O Q8 Q9~ Q@@ O O: Q O0 Q1 O Q; Q<~ Q@@ O O= Q O0 Q1 O Q> Q?~ Q@@ O O@ Q O0 Q1 O QA QB~ Q@@ O OC Q O0 Q1 O QD QE~ Q@@ O OF Q O0 Q1 O QG QH~ Q@@ O OI Q O0 Q1 O QJ QK~ Q@@ O OL Q O0 Q1 O QM QN~ Q@@ O OO Q O0 Q1 O QP QQ~ Q@@ O OR Q O0 Q1 O QS QT~ Q@@ O OU Q O0 Q1 O QV QW~ Q@@ O OX Q O0 Q1 O QY QZ~ Q@ O Z[ Q U0 Q1 U\ U] O^~ Q@ O Z_ Q U0 Q1 U\ U` Oa~ Q@ O Zb Q U0 Q1 U\ Uc Od~ Q@ O Ze Q U0 Q1 U\ Uf Og~ Q@ O Zh Q U0 Q1 U\ Ui OjD@l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? ~ Q@ O Zk Q U0 Q1 U\ Ul Om~ !Q@ !O !Zn !Q !U0 !Q1 !U\ !Uo !Op~ "Q@ "O "Zq "Q "U0 "Q1 "U\ "Ur "Os~ #Q@ #O #Zt #Q #U0 #Q1 #U\ #Uu #Ov~ $Q@ $O $Zw $Q $U0 $Q1 $U\ $Ux $Oy~ %Q@ %O %Yz %Q %U0 %Q1 %U\ %U{ %O|~ &Q@ &O &Z} &Q &U0 &Q1 &U~ &U &O~ 'Q@ 'O 'Z 'Q 'U0 'Q1 'U~ 'U 'O~ (Q@ (O (Z (Q (U0 (Q1 (U~ (U (O~ )Q@ )O )Z )Q )U0 )Q1 )U~ )U )O~ *Q@ *O *Z *Q *U0 *Q1 *U *U *O~ +Q@ +O +Z +Q +U0 +Q1 +U +U +O~ ,Q@ ,O ,Z ,Q ,U0 ,Q1 ,U ,U ,O~ -Q@ -O -Z -Q -U0 -Q1 -U -U -O~ .Q@ .O .Z .Q .U0 .Q1 .U .U .O{~ /Q@ /Q /] /Q /^ /Q /Q /Y /^~ 0Q@ 0Q 0O 0Q% 0Q 0O 0O 0Q 0O~ 1Q@ 1Q 1O 1Q% 1Q 1O 1X 1Q| 1O~ 2Q@ 2Q 2O 2Q% 2Q 2O 2X 2Q 2O~ 3Q@@ 3O 3O 3Q 3Q 3O 3O 3Q 3Q~ 4Q@@ 4O 4O 4Q 4Q 4O 4O 4Q 4Q~ 5Q@ 5Q 5Q 5Q 5O 5Q 5O 5Q 5Q~ 6Q@@ 6O 6^ 6Q 6Q 6Q 6Q 6Q 6Q~ 7O@ 7O 7O 7O% 7O 7O 7O 7Q 7O~ 8O@@ 8O 8O 8O 8O 8O 8O 8Q 8O~ 9Q@ 9Q 9O 9Q% 9Q 9O 9O 9[( 9O~ :Q@ :Q :] :Q :^ :Q :Q :Y :^~ ;O@ ;O ;O ;O ;O ;O ;O ;O ;Q)~ <Q@@ <O <O <Q <Q <O <O <Q <Q~ =Q@@ =O =O =Q =Q =O =O =Q =Q~ >Q@@ >O >O >Q >Q >O >O >Q >Q~ ?Q@@ ?O ?O ?Q ?Q ?O ?O ?Q ?QD@l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~@ A B C XD E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ~ @Q@@ @O @O @Q @Q @O @O @Q @Q~ AQ@ AQ AO AQ% AQ AO AQ' AQ AO~ BO@ BO BO BO BO BO BO BQ BO~ Ch@@ Cn Cb CR% CQ C` Cf CU CU Dm Dh DY DR DQ* DQ+ DQ DU} DQ~ Em Eh EY ER EQ* EQ+ EQ EU EQ Fh Fh FY FR FQ* FQ+ FQ FU FQ Gh Gh GY GR GQ* GQ+ GQ GU GQ Hh Hh HY HR HQ* HQ+ HQ HU HQ Ih Ih IY IR IQ* IQ+ IQ IU IQ Jh Jh JQ JR JQ* JT+ JQ JQ JQ Kh Kh KY KR KQ* KQ+ KQ KU KQ Lh LO LU LQ LQ* LT+ LP L[( LP Mh MO MU MQ MQ* MT+ MP M[( MP~ Nh@}@ NO NU NQ NQ NQ NP N[( NP Oh OO OU OQ OQ OQ OP O[( OP Ph PO PU PQ PQ PQ PP P[( PP~ QhJ@ QO QU QQ QQ QQ QP Q[( QP ~ Rh@5@ RO RU  RQ RQ RQ RP R[( RP ~ Sh@5@ SO SU  SQ SQ SQ SP S[( SP ~ Th@5@ TO TU TQ TQ TQ TP T[( TP~ Uh@5@ UO UU UQ UQ UQ UP U[( UP~ Vh@5@ VO VU VQ VQ VQ VP V[( VP~ Wh@5@ WO WU WQ WQ WQ WP W[( WP~ Xh@5@ XO XU XQ XQ XQ XP X[( XP~ Yh@5@ YO YU YQ YQ YQ YP Y[( YP~ Zh@5@ ZO ZU ZQ ZQ ZQ ZP Z[( ZP~ [h@ [O [U [Q [Q [Q [P [[( [P~ \hi@ \O \Z \Q \Q \Q \P \[( \P~ ]h@5@ ]O ]Z  ]Q ]Q ]Q ]P ][( ]P!~ ^h@5@ ^O ^Z" ^Q ^Q ^Q ^P ^[( ^P#~ _h@5@ _O _Z$ _Q _Q _Q _P _[( _P%D@l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  ~ `hB@ `O `Z& `Q `Q `Q `P `[( `P'~ ahh@ aO aZ( aQ aQ aQ aP a[( aP)~ bh@5@ bO bZ* bQ bQ bQ bP b[( bP+~ ch&@ cO cU, cQ cQ cQ cP c[( cP-~ dh=@ dO dU. dQ dQ dQ dP d[( dP/ eh eO eU0 eQ eQ eQ eP e[( eP1 fh fO fU2 fQ fQ fQ fP f[( fP3 gh gO gZ4 gQ gQ gQ gP g[( gP5~ hh@5@ hO hU6 hQ hQ hQ hP h[( hP7~ ih@5@ iO iU8 iQ iQ iQ iP i[( iP9~ jh@5@ jO jU: jQ jQ jQ jP j[( jP;~ kh@ kO kU< kQ kQ kQ kP k[( kP=~ lh=@ lO lU> lQ lQ lQ lP l[( lP?~ mh@5@ mO mU@ mQ mQ mQ mP m[( mPA~ nh@5@ nO nUB nQ nQ nQ nP n[( nPC oh oO oUD oQ oQ oQ oP o[( oPE~ ph@5@ pO pUF pQ pQ pQ pP p[( pPG~ qh@5@ qO qUH qQ qQ qQ qP q[( qPI~ rh@5@ rO rUJ rQ rQ rQ rP r[( rPK~ sh@5@ sO sUL sQ sQ sQ sP s[( sPM~ th@5@ tO tUN tQ tQ tQ tP t[( tPO~ uh@5@ uO uUP uQ uQ uQ uP u[( uPQ~ vh@5@ vO vUR vQ vQ vQ vP v[( vPS~ wh@5@ wO wUT wQ wQ wQ wP w[( wPU~ xh@5@ xO xUV xQ xQ xQ xP x[( xPW~ yh@5@ yO yUX yQ yQ yQ yP y[( yPY~ zh@5@ zO zUZ zQ zQ zQ zP z[( zP[~ {h@5@ {O {U\ {Q {Q {Q {P {[( {P]~ |h@5@ |O |U^ |Q |Q |Q |P |[( |P_~ }h@5@ }O }U` }Q }Q }Q }P }[( }Pa~ ~h@5@ ~O ~Ub ~Q ~Q ~Q ~P ~[( ~Pc~ h@5@ O Ud Q Q Q P [( PeD@l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~                                ~ h@5@ O Uf Q Q Q P [( Pg~ h@5@ O Uh Q Q Q P [( Pi h O Uj Q Q Q P [( Pk~ h@5@ O Ul Q Q Q P [( Pm~ h@5@ O Un Q Q Q P [( Po~ h@5@ O Up Q Q Q P [( Pq~ h@5@ O Ur Q Q Q P [( Ps~ h@5@ O Ut Q Q Q P [( Pu~ h@5@ O Uv Q Q Q P [( Pw~ h@5@ O Ux Q Q Q P [( Py~ h@5@ O Uz Q Q Q P [( P{~ h@5@ O U| Q Q Q P [( P}~ h@5@ O U~ Q Q Q P [( P h O U Q Q Q P [( P~ h@5@ O U Q Q Q P [( P~ h@5@ O U Q Q Q P [( P~ h@5@ O U Q Q Q P [( P~ h@5@ O U Q Q Q P [( P~ h@5@ O U Q Q Q P [( P~ h@5@ O U Q Q Q P [( P R O U Q Q Q P [( P~ h@5@ O U Q Q Q P [( P~ h@5@ O U Q Q Q P [( P~ Q@\@ h o R Q Q V U Q~ Q@\@ h o R Q Q V U Q~ Q@\@ h o R Q Q V U Q~ _@\@ h Q R Q Q V U Q~ Q@\@ h Q R Q Q V U Q~ _@\@ h i R Q Q V U Q~ Q@\@ h Q R Q Q V U Q~ Q@\@ h Q R Q Q V U Q~ Q@\@ h o R Q Q V U QD@l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~                                ~ Q@\@ h U R Q Q V U Q~ Q@\@ h U R Q Q V U Q~ Q@\@ h Y R Q Q V Q Q~ Q@\@ h Y R Q Q V V V~ h@ h U R Q Q f ` ` h h Q R% Q Q f Q Q h h Q R% Q Q f Q Q h h Q R% Q Q f Q Q h h U R% Q Q f e V h h U R% Q Q f e V h h U R% Q Q f Q Q h h Y R% Q Q Q Q Q h h Q R% Q Q f ^ Q h h U R Q Q V V V h h Y R% Q Q Q Q Q~ h\@ h l R Q Q Q Q g~ hM@ h l R% Q Q Q S g(~ hM@ h l R% Q Q Q S g(~ hM@ h l R% Q Q Q Q g(~ hM@ h l R% Q Q Q S g(~ hM@ h l R% Q Q Q Q Q~ hM@ h l R% Q Q Q Q Q~ hM@ h l R% Q Q Q Q Q~ hM@ h l R% Q Q Q Q Q~ hM@ h l R% Q Q Q Q Q~ hM@ h l R% Q Q Q Q Q~ hM@ h l R% Q Q Q Q Q~ hM@ h l R% Q Q Q Q Q ~ hM@ h l  R% Q Q Q Q  Q ~ hM@ h l  R% Q Q Q Q Q~ hM@ h j R% Q Q Q Q Q~ hM@ h l R% Q Q Q Q QD@l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~                          ,   ,   ~ hM@ h q R% Q ` Q S S~ hM@ h l R% Q Q Q Q Q~ hM@ h l R% Q Q Q Q Q~ hM@ h l R% Q Q Q S  S!~ hM@ h l" R% Q Q Q g( S~ hM@ h l# R% Q Q Q S$ S%~ hM@ h l& R% Q Q Q Q' Q(~ hM@ h l) R% Q Q Q Q* Q+~ hM@ h l, R% Q Q Q Q- Q.~ hM@ h l/ R% Q Q Q Q0 Q1~ hM@ h l2 R% Q Q f Q3 Q4~ hM@ O k5 Q Z Q P [( P6~ hM@ O k7 Q Z Q P [( P8~ hM@ O k9 Q Z Q P [( P:~ hM@ O j; Q Z Q P [( P<~ hM@ O j Q Z Q P [ P~ hM@ O k= Q Z Q P [( P>~ hM@ O j? Q Z Q P [( P@~ hM@ O jA Q Z Q P [( PB~ hM@ O kC Q Z Q P [( PD~ h@@ h j R% Q Q f QE QF~ h`@ O pG Q QH QI P [( PJ~ h`@ O pK Q QH QI P [( PL~ h@a@ O pM Q QH QI P [( PN~ h@ h TS R Q Q QT QU [( h h UV R% Q Q f QW QX h h T R% Q Q f T TY~ ht@ h TZ R% Q Q f T[ T\~ h%@ h T R% Q Q Q T] T~ h@@ O U^ Q Q Q P [( P_~ h@u@ O U` Q Q Q P [( Pa~ h@Q@ O Ub Q Q Q P [( PcD@l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~      h h YO R% Qd Qe f Qf QQ~ h@6@ h d R R a V d d h h cO R% Qm an f QP QQ~ h@U@ h c R Qm an V d d~ h@z@ h c RR Qm an Q a aP~~~~>@ggD g2 d^  dMbP?_*+%,&ffffff?'ffffff?(?)?",333333?333333?&<3U>@ggD g2 _  dMbP?_*+%,&ffffff?'ffffff?(?)?",333333?333333?&<3U>@ggD Oh+'0@H`x Erin MuhlbradtErin MuhlbradtMicrosoft Excel@K@[a՜.+,0 PXl t|  Microsoft SEND Changes 2012-12-21Sheet2Sheet3  Worksheets  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry FWorkbook^`SummaryInformation(DocumentSummaryInformation8